https://www.prosigna.com
Live programs with international breast cancer experts
We invite you to join a series of live and interactive
webinars designed for doctors treating breast cancer who are interested in
advancing personalized treatment through molecular gene expression testing.*
- Designed by your peers: Live sessions with leading breast cancer key opinion leaders.
- Interactions, debates and live discussions: interactive sessions, including key opinion leaders’ live presentations, debates and discussions.
Past Live Events
Tue 6:00 PM CEST
How can intrinsic molecular subtypes guide therapeutic decisions for breast cancer patients?
Report based discussion with Pr Frédérique Penault-Llorca, Pr Gilles Freyer and Dr Olivier Tredan.
Wed 6:00 PM CET
Helping patients understand their risk of recurrence scores
TARGET educational programme and IMPARTER study outcomes review
Tue 6:00 PM CEST
The history and evolution of PAM50 & Prosigna from the laboratory to the clinic: how accurate biological classification can be used to best treat your patients.
Live discussions and debates looking at the history and origins of PAM50 and Prosigna and the adoption process in a reference center in Germany: Heidelberg.
Thu 6:00 PM CEST
The potential of Prosigna
What are the advantages of using a second-generation genomic test? What is the utility of intrinsic subtyping in the clinic? The past, present and future.
